The evaluation of lipid peroxidation and acute effect of octreotide on lipid peroxidation in patients with active acromegaly

Clinica Chimica Acta

Volumn 336, Issue 1-2, 2003, Pages 45-48

  Yarman, Sema ^a   Özden, Tülin Ayse ^b   Gökkuşu, Cahide ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Acromegaly; Lipid peroxidation; Octreotide

Indexed keywords

OCTREOTIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ACROMEGALY; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EVALUATION; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL;

EID: 0142247153     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00328-0     Document Type: Article

References (9)

1. Gutteridge J.M.C. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin. Chem. 41:1995;1819-1828.
2. Kehrer J.P. Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol. 23:1993;21-48.
3. Melmed S., Jackson I., Kleinberg D., Kibanski A. Current treatment guidelines for acromegaly. J. Clin. Endocrinol. Metab. 83:1998;2646-2652.
4. Newman C.B., Melmed S., George A., Torigian D., Duhaney M., Snyder P.et al. Octreotide as primary treatment for acromegaly. J. Clin. Endocrinol. Metab. 83:1998;23034-23040.
5. Wenger F.A., Kilian M., Jacobi C.A., Mautsch I., Peter F.J., Gushi H.et al. Effects of octreotide on liver metastasis and intrametastatic lipid peroxidation in experimental pancreatic cancer. Oncology. 60:2001;282-288.
6. Wenger F.A., Kilian M., Mautsch I., Jacobi C.A., Steiert A., Peter F.J. et al. Influence of octreotide on liver metastasis and hepatic lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters. Pancreas. 23:2001;266-272.
7. Yoshioka T., Kawada K., Shimada T., Mori M. Lipid peroxidation in maternal and cord blood and protective mechanisms against activated oxygen toxicity in the blood. Am. J. Obstet. Gynecol. 135:1979;372-376.
8. Brown-Borg H.M., Rakoczy S.G., Romanick M.A., Kennedy M.A. Effects of growth hormone and insulin-like growth factor-1 on hepatocyte antioxidative enzymes. Exp. Biol. Med. (Maywood). 227:2002;94-104.
9. Gillis J.C., Noble S., Goa K.L. Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegaly. Drugs. 53:1997;681-699.